Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Crohn'S & Colitis|September 19, 2025
Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potentialMichael Colwill, Sebastian Povlsen, Richard Pollok, et al.
Journal of Clinical Medicine|February 13, 2025
Role of Mirikizumab in the Treatment of Inflammatory Bowel Disease-From Bench to BedsideMichael Colwill, Samantha Baillie, Jennifer Clough, et al.
Gut|April 29, 2026
Digital twins in IBD-bridging data, biology and trial innovationMichael Colwill, Sailish Honap, Anna-Mary Young, et al.
Future Healthcare Journal|April 4, 2022
Unlocking the benefits of the Baveno VI guidance when screening for varices: an audit of clinical practice across LondonMichael Colwill, Luke Lake, Ahmed El-Sayed, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|December 11, 2025
Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary centerMichael Colwill, Jessica Padley, Umang Qazi, et al.
European Journal of Gastroenterology & Hepatology|January 3, 2020
A 'real-world' analysis of risk factors for post liver transplant delirium and the effect on length of stayOliver D Tavabie, Michael Colwill, Robbie Adamson, et al.
Drugs in Context|February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centresDavid Young, Sohail Rahmany, Deborah Taylor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitisSailish Honap, Joelle St-Pierre, Michael Colwill, et al.
Pageof 3